Peptide & GLP-1 Medication Guide

Research 38 peptide and GLP-1 medications with clinical details and provider availability.

• AOD-9604 — A modified fragment (amino acids 176-191) of human growth hormone designed to stimulate fat metabolism without the growth-promoting effects of full HG
• BPC-157 — A synthetic peptide derived from a protective protein found in human gastric juice. Widely studied for its regenerative properties on tendons, ligamen
• CJC-1295 / Ipamorelin — A combination of a growth hormone-releasing hormone analog (CJC-1295) and a growth hormone secretagogue (Ipamorelin). Together they stimulate natural
• Dihexa — A small molecule peptidomimetic derived from angiotensin IV that potently activates the HGF/Met signaling system. Animal studies show cognitive enhanc
• DSIP — A naturally occurring nonapeptide first isolated from rabbit brain in 1977. DSIP modulates sleep architecture, stress responses, and neuroendocrine fu
• Epithalon — A synthetic tetrapeptide studied for its ability to activate telomerase, the enzyme responsible for maintaining telomere length. Research suggests pot
• FOXO4-DRI — A D-amino acid retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells, triggering apoptosis of these 'zomb
• GHK-Cu — A naturally occurring copper-binding peptide found in human plasma. Declines with age and is used therapeutically for skin rejuvenation, wound healing
• GHRP-2 — A synthetic hexapeptide that stimulates pituitary growth hormone secretion by binding ghrelin receptors. Produces strong, pulsatile GH release without
• GHRP-6 — One of the original synthetic growth hormone secretagogues. Similar to GHRP-2 but with a pronounced ghrelin-mimicking appetite-stimulating effect. Fav
• Gonadorelin — A synthetic version of the body's natural gonadotropin-releasing hormone (GnRH). Used to stimulate the pituitary gland to release luteinizing hormone
• Hexarelin — A synthetic growth hormone secretagogue peptide (GHSP) that stimulates growth hormone release by activating the ghrelin receptor (GHS-R1a). Studied fo
• HGH Fragment 176-191 — The lipolytic fragment of human growth hormone (amino acids 176-191). Stimulates fat burning and inhibits lipogenesis without the metabolic side effec
• IGF-1 LR3 — A long-acting analog of insulin-like growth factor-1 (IGF-1) with an arginine substitution that reduces binding to IGF-binding proteins, extending its
• Ipamorelin — A selective growth hormone secretagogue receptor (GHSR) agonist that stimulates pulsatile growth hormone release without significantly raising cortiso
• Kisspeptin — A hypothalamic neuropeptide that acts as the primary regulator of the reproductive endocrine axis, triggering GnRH release and downstream LH/FSH produ
• KPV — A tripeptide fragment derived from the C-terminus of alpha-melanocyte-stimulating hormone (α-MSH). KPV carries the anti-inflammatory properties of α-M
• Liraglutide — A GLP-1 receptor agonist administered daily for chronic weight management. FDA-approved as Saxenda for obesity and as Victoza for type 2 diabetes. One
• LL-37 — The only known human cathelicidin antimicrobial peptide, naturally produced by immune cells and epithelial tissues. LL-37 has broad-spectrum antimicro
• Melanotan II — A synthetic melanocortin peptide analog that activates multiple melanocortin receptors. Originally studied for tanning, it also has effects on sexual
• MK-677 — An oral growth hormone secretagogue that mimics the action of ghrelin, stimulating growth hormone release from the pituitary gland. Unlike injectable
• MOTS-c — A mitochondria-derived peptide encoded within the mitochondrial genome. MOTS-c regulates metabolic homeostasis, enhances insulin sensitivity, and has
• NAD+ — A coenzyme found in every living cell, critical for energy metabolism and cellular repair. Levels decline with age, and supplementation is used to sup
• Oxytocin — A nonapeptide produced in the hypothalamus and released by the posterior pituitary. Often called the 'bonding hormone,' oxytocin modulates social beha
• P21 — A 21-amino-acid peptide that mimics the action of ciliary neurotrophic factor (CNTF). Studied for neurogenesis, cognitive improvement, and neuroprotec
• Pentadeca Arginate — A stable arginate salt form of a 15-amino-acid sequence related to BPC-157. Developed as a compounding-pharmacy-compatible alternative following FDA r
• PT-141 — A melanocortin receptor agonist that works through the central nervous system to improve sexual arousal. FDA-approved as Vyleesi for hypoactive sexual
• RAD-140 — A selective androgen receptor modulator (SARM) investigated for muscle wasting and breast cancer. Not a peptide by structure but commonly grouped with
• Retatrutide — A next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Phase 3 clinical trials show weight loss exceeding tirze
• Selank — A synthetic peptide derived from the naturally occurring immunomodulatory peptide tuftsin. Developed as an anxiolytic with nootropic properties, it mo
• Semaglutide — A GLP-1 receptor agonist originally developed for type 2 diabetes, now widely prescribed for weight management. Reduces appetite and slows gastric emp
• Semax — A synthetic peptide derived from adrenocorticotropic hormone (ACTH) fragment 4-10. Developed in Russia for cognitive enhancement and neuroprotection,
• Sermorelin — A growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to produce and secrete growth hormone naturally. Often used as a
• SS-31 — A mitochondria-targeting tetrapeptide that concentrates in the inner mitochondrial membrane, protecting cardiolipin from oxidative damage. Restores mi
• TB-500 — A synthetic fragment of thymosin beta-4, a naturally occurring peptide involved in tissue repair and regeneration. Studied for its ability to promote
• Tesamorelin — An FDA-approved growth hormone-releasing factor analog originally indicated for HIV-associated lipodystrophy. Increasingly used off-label for body com
• Thymosin Alpha-1 — A naturally occurring peptide first isolated from the thymus gland. FDA-orphan-drug designated, it enhances immune function by stimulating T-cell matu
• Tirzepatide — A dual GIP/GLP-1 receptor agonist for weight management and type 2 diabetes. Clinical trials show significant weight reduction, often exceeding semagl